Cervical Carcinoma — Research

Cervical Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	87,797	`("Cervical Carcinoma"[tiab] OR "Cervical Cancer"[tiab] OR "Cervix Carcinoma"[tiab] OR "Carcinoma of Cervix"[tiab] OR "Cervix Uteri Carcinoma"[tiab] OR "Carcinoma of the Cervix"[tiab] OR "Uterine Cervix Carcinoma"[tiab] OR "Carcinoma of Cervix Uteri"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	27,302	`("Cervical Carcinoma"[tiab] OR "Cervical Cancer"[tiab] OR "Cervix Carcinoma"[tiab] OR "Carcinoma of Cervix"[tiab] OR "Cervix Uteri Carcinoma"[tiab] OR "Carcinoma of the Cervix"[tiab] OR "Uterine Cervix Carcinoma"[tiab] OR "Carcinoma of Cervix Uteri"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	5,795	`("Cervical Carcinoma"[tiab] OR "Cervical Cancer"[tiab] OR "Cervix Carcinoma"[tiab] OR "Carcinoma of Cervix"[tiab] OR "Cervix Uteri Carcinoma"[tiab] OR "Carcinoma of the Cervix"[tiab] OR "Uterine Cervix Carcinoma"[tiab] OR "Carcinoma of Cervix Uteri"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (9)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–9 of 9 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.
· Br J Cancer · 2011 · PMID 21730982 · validated civic_curation pubmed
Toward the molecular dissection of peritoneal pseudomyxoma.
· Ann Oncol · 2016 · PMID 27502722 · validated civic_curation pubmed
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
· J Transl Med · 2016 · PMID 27154293 · validated civic_curation pubmed
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.